Search

Displaying results 9331 - 9340 of 10000 in total
  1. Drug

    Bucloxic acid

    go.drugbank.com/drugs/DB20877
    Experimental

    Bucloxic acid has a monoisotopic molecular weight of 294.1 Da.

  2. Drug

    Sorbitan monostearate

    go.drugbank.com/drugs/DB20996
    Experimental

    Sorbitan monostearate has a monoisotopic molecular weight of 430.33 Da.

  3. Drug

    Furacrinic acid

    go.drugbank.com/drugs/DB21223
    Experimental

    Furacrinic acid has a monoisotopic molecular weight of 258.09 Da.

  4. Drug

    Xantofyl palmitate

    go.drugbank.com/drugs/DB21273
    Experimental

    Xantofyl palmitate has a monoisotopic molecular weight of 1044.89 Da.

  5. Drug

    Cromoglicate lisetil

    go.drugbank.com/drugs/DB21297
    Experimental

    Cromoglicate lisetil has a monoisotopic molecular weight of 652.23 Da.

  6. Drug

    Iobutoic acid

    go.drugbank.com/drugs/DB21443
    Experimental

    Iobutoic acid has a monoisotopic molecular weight of 670.82 Da.

  7. Drug

    Velafermin

    go.drugbank.com/drugs/DB06493
    Investigational

    Velafermin was investigated as a potential therapy for the prevention and treatment of oral mucositis by fostering the regeneration and repair of the cells lining the gastrointestinal tract.

  8. Drug

    Erythroxylum catuaba bark

    go.drugbank.com/drugs/DB14300
    Investigational

    "Catuaba" is a general term for a medicinal infusion created by the bark of plants belonging to the _Erythroxylum_ genus, though this name is also applied to infusions of plants belonging to other genera

  9. Drug

    Valopicitabine

    go.drugbank.com/drugs/DB13920
    Investigational

    The 3-O-valine ester prodrug of the nucleoside analog 2'-C-methylcytidine with anti-hepatitis C virus (HCV) activity. … This blocks viral production of HCV RNA and thus viral replication. [from NCI]

    Synonyms: 2'-C-methylcytidine 3'-O-L-valinyl ester
  10. Drug

    Abivertinib

    go.drugbank.com/drugs/DB15327
    Investigational

    [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. … Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK).